The global Aspergillosis Drugs market is witnessing steady growth, driven by the increasing incidence of Aspergillosis infections, advancements in antifungal drug development, and the rising number of organ transplantation procedures. The Aspergillosis Drugs market was valued at US$ 1.32 billion in 2025 and is expected to reach US$ 2.44 billion by 2034, registering a CAGR of 7.06% during...